Nanoform Finland Oyj NANOFH.HE · EUR

Its shares trade on Nasdaq Helsinki under the ticker NANOFH.HE. It has been listed since 4 June 2020. In the fiscal year to 31 December 2025, it reported revenue of €3.5m and a net loss of €17.9m. At that date it held total assets of €54.0m and shareholders' equity of €42.8m.

Nanoform Finland Oy engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen. The company went IPO on 2020-06-04. The Company’s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Miguel CaladoNon-Executive Independent Chairman of the Board€405,094
• Dr. Edward HaeggstromChief Executive Officer, Member of the Management Board
• Mr. Albert HaeggstromChief Financial Officer, Member of the Management Board, Director, since 2015€419,749
• Mr. Peter HanninenGeneral Counsel, Member of the Management Board
• Ms. Johanna TuomistoDirector of Human Resources, Member of the Management Board
• Dr. Goncalo AndradeChief of Business Operations, Member of the Management Board
• Mr. Antonio Da SilvaChief Business Officer, Member of the Management Board
• Mr. Christian JonesChief Commercial Officer, Member of the Management Board
• Dr. David RoweHead of Manufacturing, Member of the Management Board
• Ms. Jeanne ThomaIndependent Director€54,777
• Mr. Henri HaartmanDirector of Investor Relations, since 2022

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.